Skip to main content
. 2009 Jun 1;77(8):3380–3388. doi: 10.1128/IAI.00358-09

TABLE 1.

Peptide and recombinant proteins used in this study

Description Sequence
Synthetic peptides
    MAP peptidea GNAEVHASFFDIGGS\ /GNAEVHASFFDIGGS
K-K-K
GNAEVHASFFDIGGS/ \GNAEVHASFFDIGGS
    PA 305-319 peptide GNAEVHASFFDIGGS
    Irrelevant peptideb DAEFRHDSGYEVHHQK
Recombinant proteins
    MBP-PA 305-319c MBP-(GNAEVHASFFDIGGS)2
    MBP-PA 299-327c MBP-(HTSEVHGNAEVHASFFDIGGSVSAGFSNS)2
a

The MAP peptide consists of four PA 305-319 peptide arms extending from the α- and ε-amino groups of a branching lysine core indicated by “K-K-K.”

b

The irrelevant peptide sequence is from the Aβ peptide comprising aa 1 to 16, derived from the amyloid precursor protein.

c

The recombinant proteins consist of maltose binding protein (MBP) expressed as fusions with two tandem copies of the peptide sequences shown.

HHS Vulnerability Disclosure